SPAC1B3.01c Antibody

What is SPAC1B3.01c and why would researchers need an antibody against it?

SPAC1B3.01c is a protein-coding gene in fission yeast (Schizosaccharomyces pombe) that encodes a putative uracil phosphoribosyltransferase . This enzyme is involved in nucleotide metabolism, specifically in the pyrimidine salvage pathway. Researchers would require antibodies against this protein for several fundamental reasons: to study protein expression levels, to determine subcellular localization through immunofluorescence microscopy, to investigate protein-protein interactions via co-immunoprecipitation experiments, and to assess post-translational modifications. The protein has been included in proteome-wide interactome studies, suggesting its potential involvement in protein interaction networks that may be crucial for understanding yeast cellular processes .

How can I validate the specificity of an SPAC1B3.01c antibody?

Validating antibody specificity is a critical first step before proceeding with any experiment. For SPAC1B3.01c antibodies, several methodological approaches should be employed:

• Western blot analysis: Using wild-type yeast strains alongside SPAC1B3.01c deletion mutants. A specific antibody should detect a band of the expected molecular weight (based on the amino acid sequence) in wild-type samples but not in deletion mutants.

• Recombinant protein controls: Test the antibody against purified recombinant SPAC1B3.01c protein. Similar to approaches used with other proteins, this can confirm direct binding to the target protein .

• Cross-reactivity assessment: Evaluate potential cross-reactivity with related proteins, particularly other uracil phosphoribosyltransferases from different species. This is especially important when the antibody is designed against conserved domains .

• Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody is capturing the intended protein and identify any non-specific interactions.

What experimental applications are suitable for SPAC1B3.01c antibodies?

SPAC1B3.01c antibodies can be utilized in numerous experimental applications, depending on the specific research questions:

• Western blotting: For quantitative analysis of protein expression levels across different conditions or genetic backgrounds. The protocols would be similar to those established for antibodies like anti-PU.1, where specific detection conditions (reducing conditions, appropriate buffer groups) need to be optimized .

• Immunofluorescence microscopy: To determine the subcellular localization of SPAC1B3.01c protein within yeast cells. This is particularly valuable for proteins involved in metabolic pathways to understand their compartmentalization.

• Chromatin immunoprecipitation (ChIP): If SPAC1B3.01c has any DNA-binding capabilities or associates with chromatin-bound complexes.

• Co-immunoprecipitation: To identify protein interaction partners, building upon existing interactome data .

• Flow cytometry: For quantitative analysis of protein expression in individual cells, similar to applications demonstrated with other antibodies .

How should I optimize fixation and permeabilization when using SPAC1B3.01c antibodies for immunofluorescence in yeast cells?

Optimizing fixation and permeabilization for yeast cells requires special consideration due to their rigid cell wall:

• Fixation protocol: For S. pombe cells, a combination approach often works best:

  • Begin with 3.7% formaldehyde fixation for 30 minutes at room temperature

  • Follow with cell wall digestion using zymolyase (1 mg/mL) for 30-60 minutes at 37°C

  • Monitor spheroplast formation microscopically

• Permeabilization options:

  • For nuclear proteins: 0.1% Triton X-100 for 5 minutes

  • For membrane-associated proteins: 0.05% saponin (similar to techniques used with THP-1 cells)

  • For cytoplasmic proteins: 0.1-0.5% NP-40 for 10 minutes

• Blocking solution optimization: Use 5% BSA or 10% normal serum from the species in which the secondary antibody was raised to minimize background.

• Antibody concentration: Start with 1-5 μg/mL (similar to concentrations used for other cellular applications) and titrate as needed based on signal-to-noise ratio.

If background fluorescence remains problematic, pre-adsorption of the antibody with fixed wild-type yeast cells lacking the target protein can reduce non-specific binding.

What are the optimal storage and handling conditions for maintaining SPAC1B3.01c antibody activity?

Proper storage and handling of antibodies is crucial for maintaining their activity and specificity:

• Long-term storage:

  • Store at -20°C to -70°C for up to 12 months from date of receipt

  • Avoid repeated freeze-thaw cycles by preparing small aliquots

• After reconstitution:

  • Store at 2-8°C for up to 1 month under sterile conditions

  • For longer storage (up to 6 months), keep at -20°C to -70°C

• Working dilutions:

  • Prepare fresh working dilutions on the day of the experiment

  • If storing diluted antibody, add carrier protein (0.1% BSA)

• Shipping and temporary storage:

  • Can be shipped at ambient temperature

  • Upon receipt, should be immediately stored according to manufacturer recommendations

A critical note is that storage buffer composition affects stability - antibodies in glycerol-containing buffers (typically 50% glycerol) show better resistance to freeze-thaw cycles than those in plain buffer solutions.

How can I troubleshoot weak or absent signals when using SPAC1B3.01c antibodies in Western blotting?

When encountering weak or absent signals in Western blotting with SPAC1B3.01c antibodies, systematically address these potential issues:

• Protein expression levels:

  • SPAC1B3.01c may be expressed at low levels under standard conditions

  • Consider using cells from different growth phases or stress conditions to induce expression

  • Use enrichment techniques like immunoprecipitation before Western blotting

• Protein extraction optimization:

  • For yeast cells, mechanical disruption (glass beads) combined with detergent lysis often yields best results

  • Add protease inhibitors to prevent degradation

  • Use reducing conditions if the antibody was developed against a reduced epitope

• Transfer efficiency:

  • Check transfer efficiency with reversible protein stains

  • For high molecular weight proteins, extend transfer time or reduce gel percentage

  • For hydrophobic proteins, increase SDS or methanol in transfer buffer

• Detection settings:

  • Increase antibody concentration (try 2-5 μg/mL as used in documented Western blot protocols)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use more sensitive detection systems (ECL Plus instead of standard ECL)

  • Consider signal amplification systems

• Epitope accessibility:

  • If the epitope might be masked, try different denaturing conditions

  • Consider using different antibody clones that recognize different epitopes

How can I use SPAC1B3.01c antibodies in spatial biology approaches to understand protein localization changes during cell cycle progression?

Spatial biology approaches can reveal dynamic changes in SPAC1B3.01c localization throughout the cell cycle:

• Multiplex immunofluorescence imaging:

  • Combine SPAC1B3.01c antibody with cell cycle markers (e.g., Cdc13 for G2/M transition)

  • Use purified antibodies from different species to avoid cross-reactivity

  • Apply spectral unmixing to resolve overlapping fluorescence signals

• Live-cell imaging with tagged proteins:

  • Compare fixed-cell antibody staining patterns with live-cell imaging of GFP-tagged SPAC1B3.01c to validate localization

  • Use cell synchronization methods (nitrogen starvation followed by release or elutriation) to enrich for specific cell cycle phases

• Super-resolution microscopy approaches:

  • STORM or PALM microscopy can provide nanoscale resolution of protein localization

  • Requires specialized secondary antibodies (conjugated to appropriate fluorophores)

  • Can reveal colocalization with other proteins at subdiffraction resolution

• Correlative light and electron microscopy (CLEM):

  • Combine immunofluorescence with electron microscopy to precisely locate SPAC1B3.01c relative to ultrastructural features

  • Particularly useful if SPAC1B3.01c associates with specific organelles or membrane structures

This approach has revealed important insights about other proteins' spatial distribution and can be applied to understanding the functional significance of SPAC1B3.01c localization patterns .

What considerations should be made when designing co-immunoprecipitation experiments to identify SPAC1B3.01c protein interaction partners?

Designing effective co-immunoprecipitation (co-IP) experiments for SPAC1B3.01c requires careful consideration of multiple factors:

• Lysis conditions optimization:

  • Test different buffers: HEPES-based buffers (pH 7.4) preserve many interactions

  • Detergent selection is critical: start with 0.5% NP-40 or 0.1% Triton X-100

  • Salt concentration: typically 150 mM NaCl, but may need optimization

  • Include phosphatase inhibitors if studying phosphorylation-dependent interactions

• Antibody orientation strategies:

  • Direct approach: Immobilize SPAC1B3.01c antibody to resin first, then add lysate

  • Indirect approach: Form antibody-antigen complexes in solution, then capture with Protein A/G

  • Consider using epitope-tagged SPAC1B3.01c as an alternative approach

• Controls to include:

  • Input (pre-IP lysate) to confirm protein expression

  • IgG control from the same species as the SPAC1B3.01c antibody

  • Lysate from SPAC1B3.01c knockout strain

  • Peptide competition assay to verify specificity

• Detection methods:

  • Western blot for known or suspected interactors

  • Mass spectrometry for unbiased discovery of novel interaction partners

  • Consider SILAC or TMT labeling for quantitative comparison between conditions

• Validation approaches:

  • Reverse co-IP using antibodies against identified partners

  • Proximity ligation assay to confirm interactions in intact cells

  • Functional assays to determine biological significance

This approach aligns with established proteome-wide interactome studies that have included SPAC1B3.01c in their analyses .

How can I adapt ChIP-seq protocols to investigate potential DNA interactions of SPAC1B3.01c in fission yeast?

While SPAC1B3.01c is annotated as a uracil phosphoribosyltransferase, investigating potential DNA interactions through ChIP-seq requires specialized adaptations for yeast cells:

• Crosslinking optimization:

  • Standard: 1% formaldehyde for 15 minutes at room temperature

  • For weaker protein-DNA interactions: Add a protein-protein crosslinker (DSG, 2 mM) before formaldehyde

  • Quench with glycine (125 mM final concentration)

• Cell wall disruption:

  • Enzymatic: Zymolyase treatment (10 mg/mL, 30 minutes at 30°C)

  • Mechanical: Glass bead disruption in lysis buffer

  • Combined approach often yields best results

• Sonication parameters:

  • Use Covaris or Bioruptor with optimized settings for S. pombe

  • Target fragment size: 200-300 bp

  • Verify fragment size by agarose gel electrophoresis

• Immunoprecipitation considerations:

  • Pre-clear lysate with Protein A/G beads

  • Use 5-10 μg of SPAC1B3.01c antibody per IP reaction

  • Include input control and IgG control

  • Increase wash stringency to reduce background

• Library preparation and sequencing:

  • Use specialized kits designed for low-input samples

  • Include spike-in controls for normalization

  • Sequence to a depth of at least 20 million reads per sample

• Data analysis pipeline:

  • Align to the S. pombe genome (use latest assembly)

  • Peak calling with MACS2 or similar algorithm

  • Motif analysis with MEME suite

  • Integration with RNA-seq or other genomic data

This protocol adaptation accounts for the unique challenges of performing ChIP-seq in yeast cells while maintaining the sensitivity needed to detect potential non-canonical functions of SPAC1B3.01c.

How do antibody-based techniques for studying SPAC1B3.01c compare with genetic tagging approaches?

Comparing antibody-based detection of endogenous SPAC1B3.01c with genetic tagging approaches presents important trade-offs:

The choice between these approaches should be guided by:

• Research question specificity: For studying dynamic localization during cell cycle, fluorescent tagging may be superior. For studying post-translational modifications, antibody-based approaches offer advantages.

• Control experiments: When using genetic tags, confirm that the tag doesn't disrupt protein function through complementation assays. For antibodies, validate specificity as outlined in question 1.2.

• Combined approaches: For strongest evidence, use both methods in parallel - antibody detection of untagged protein and tag-based detection in a separate strain.

This comparative analysis is supported by extensive research on protein localization in fission yeast, including global studies that have mapped the S. pombe proteome .

What methodological considerations should be addressed when using SPAC1B3.01c antibodies in evolutionarily distant species?

Using antibodies developed against S. pombe SPAC1B3.01c to detect orthologous proteins in other species requires careful methodological considerations:

• Sequence conservation analysis:

  • Perform sequence alignment between SPAC1B3.01c and potential orthologs

  • Focus on epitope regions if known (request this information from antibody manufacturers)

  • Higher conservation in the epitope region increases cross-reactivity likelihood

• Cross-reactivity prediction:

  • The homology between S. pombe SPAC1B3.01c and other species' orthologs varies:

    • Human UPRT: Moderate conservation

    • S. cerevisiae FUR1: Higher conservation

    • Other fungal orthologs: Variable conservation

• Validation strategies for cross-species applications:

  • Recombinant protein controls from the target species

  • Knockout/knockdown controls in the target species

  • Preabsorption with recombinant target species protein

  • Western blot comparison of band patterns between species

• Protocol adaptations:

  • Cell/tissue preparation methods differ between species

  • Buffer optimization may be required (pH, salt concentration)

  • Incubation times and temperatures may need adjustment

  • Fixation methods should be optimized for each species

• Sensitivity enhancement approaches:

  • Signal amplification (e.g., tyramide signal amplification)

  • More sensitive detection systems (Super Signal West Femto)

  • Longer exposure times for Western blots

  • Immunoprecipitation before Western blotting

This cross-species application approach should be guided by the known evolutionary relationships between uracil phosphoribosyltransferases across species, as documented in comparative genomic studies .

How can I integrate antibody-based detection of SPAC1B3.01c with transcriptomic and proteomic datasets to understand its role in cellular stress responses?

Integrating antibody-based detection with multi-omics data provides a comprehensive view of SPAC1B3.01c function in stress responses:

• Experimental design for multi-omics integration:

  • Expose S. pombe cells to relevant stressors (oxidative, heat, nutrient deprivation)

  • Collect parallel samples for:

    • Antibody-based protein quantification (Western blot/IF/flow cytometry)

    • Transcriptomics (RNA-seq)

    • Proteomics (MS-based)

    • Metabolomics (focusing on nucleotide metabolism)

  • Include appropriate time points to capture dynamic responses

• Antibody-based approaches to capture specific features:

  • Use phospho-specific antibodies if SPAC1B3.01c is regulated by phosphorylation

  • Apply cellular fractionation before Western blotting to detect translocation events

  • Employ proximity ligation assays to identify stress-induced protein interactions

  • Utilize ChIP-seq to identify potential stress-responsive DNA binding (if applicable)

• Data integration strategies:

  • Temporal alignment of datasets using statistical methods

  • Correlation analysis between transcript and protein levels

  • Network analysis to identify functional modules

  • Pathway enrichment analysis incorporating SPAC1B3.01c interactions

• Validation of integrated insights:

  • Genetic manipulation (deletion, point mutations) of SPAC1B3.01c

  • Chemical inhibition of uracil phosphoribosyltransferase activity

  • Rescue experiments with wild-type vs. mutant SPAC1B3.01c

  • Computational modeling to test hypotheses derived from integrated data

This multi-omics approach builds upon previous research showing SPAC1B3.01c involvement in stress responses and enables a more comprehensive understanding of its functional role beyond its annotated enzymatic activity.

How can spatial transcriptomics be combined with SPAC1B3.01c antibody staining to understand the relationship between localized translation and protein function?

Combining spatial transcriptomics with SPAC1B3.01c antibody detection creates a powerful approach to understand the spatial relationship between mRNA localization and protein distribution:

• Sequential workflow optimization:

  • Perform antibody staining first, image, then proceed with spatial transcriptomics

  • Alternatively, use computational alignment of serial sections

  • Consider multiplexed detection systems that allow simultaneous visualization of proteins and transcripts

• Technical implementation:

  • Fixed cell preparation preserving both protein epitopes and RNA integrity

  • Use of RNase inhibitors during antibody staining steps

  • Optimization of permeabilization to allow probe access while maintaining antigen detection

  • Selection of compatible fluorophores to avoid spectral overlap

• Analysis approaches:

  • Colocalization analysis between SPAC1B3.01c mRNA and protein

  • Spatial correlation statistics to identify regions of co-enrichment or exclusion

  • Single-cell resolution analysis to detect heterogeneity in mRNA-protein relationships

  • Time-course studies to detect temporal dynamics in protein synthesis and localization

• Functional validation experiments:

  • mRNA localization element mutants to disrupt spatial patterns

  • Local translation inhibition experiments

  • Fluorescent timer protein fusions to distinguish old from newly synthesized proteins

This integrated approach leverages recent advances in spatial biology techniques and can reveal whether SPAC1B3.01c undergoes local translation in specific subcellular compartments, which could explain any observed spatial heterogeneity in its distribution or function.

What considerations should be made when developing phospho-specific antibodies against SPAC1B3.01c for studying its regulation?

Developing and utilizing phospho-specific antibodies against SPAC1B3.01c requires specialized approaches:

• Predictive bioinformatics analysis:

  • Use phosphorylation prediction algorithms (NetPhos, GPS) to identify potential sites

  • Evaluate conservation of predicted sites across species

  • Identify kinase motifs that may suggest regulatory pathways

  • Analyze structural models to assess surface accessibility of phosphosites

• Phosphopeptide design strategy:

  • Select peptides containing the phosphorylation site plus 7-10 flanking amino acids

  • Ensure unique sequence compared to other proteins in S. pombe

  • Consider both N-terminal and C-terminal coupling approaches

  • Include both phosphorylated and non-phosphorylated peptides for screening

• Validation requirements for phospho-specific antibodies:

  • Western blot comparison with general SPAC1B3.01c antibody

  • Phosphatase treatment controls to confirm phospho-specificity

  • Mutagenesis of the phosphorylation site (S/T/Y to A) as negative control

  • Correlation with mass spectrometry phosphoproteomics data

  • Signal induction under conditions known to activate relevant kinases

• Application-specific considerations:

  • For Western blotting: Include phosphatase inhibitors during sample preparation

  • For immunoprecipitation: Use phospho-specific antibodies to enrich phosphorylated forms

  • For immunofluorescence: Optimize fixation to preserve phosphoepitopes (avoid methanol)

  • For flow cytometry: Similar to protocols established for other phospho-antibodies

This methodological approach enables the study of regulatory mechanisms controlling SPAC1B3.01c function through phosphorylation, which may reveal condition-specific activation or inhibition of its enzymatic activity.

How can single-molecule approaches using SPAC1B3.01c antibodies provide insights into its molecular function and dynamics?

Single-molecule approaches offer unprecedented insights into SPAC1B3.01c behavior at the molecular level:

• Single-molecule imaging methodologies:

  • Single-molecule FRET using differentially labeled antibodies or antibody fragments

  • Direct stochastic optical reconstruction microscopy (dSTORM) for nanoscale localization

  • Single-particle tracking with quantum dot-conjugated antibodies

  • Near-field scanning optical microscopy (NSOM) for membrane-proximal visualization

• Experimental design considerations:

  • Antibody fragmentation (Fab generation) to minimize steric hindrance

  • Direct fluorophore conjugation strategies to achieve 1:1 antibody:fluorophore ratio

  • Use of oxygen scavenger systems to reduce photobleaching

  • Microfluidic systems for rapid environment modulation during imaging

• Quantitative parameters measurable with single-molecule approaches:

  • Diffusion coefficients in different cellular compartments

  • Residence times at specific subcellular locations

  • Conformational changes (if using FRET pairs targeting different epitopes)

  • Oligomerization states and complex formation dynamics

  • Interaction kinetics with binding partners

• Analysis frameworks for single-molecule data:

  • Mean square displacement analysis for diffusion characteristics

  • Hidden Markov modeling for state transitions

  • Single-particle tracking and motion classification

  • Cluster analysis for mapping interaction hotspots

This technology leverages recent advances in spatial biology and purified antibody applications to move beyond ensemble averages and reveal the heterogeneous behaviors of individual SPAC1B3.01c molecules, potentially uncovering rare or transient functional states that are masked in bulk measurements.